<DOC>
	<DOCNO>NCT02323438</DOCNO>
	<brief_summary>A single-center , randomize , control , switch , open-label , parallel cohort study . Smoking subject confine clinic 9 day . During stay , baseline assessment ad libitum smoke occur first 3 day . Following baseline , subject switch either Electronic Cigarette Nicotine Gum , post-product switch assessment occur 6 day .</brief_summary>
	<brief_title>Assess Biomarkers Tobacco Exposure Nicotine Pharmacokinetics Smokers After 5-Day In-Clinic Confinement Switch Electronic Cigarette Nicotine Gum</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>1 . Able read , understand , willing sign Informed Consent Form ( ICF ) complete questionnaire write English ; 2 . Generally healthy male female , 21 60 year age ( inclusive ) ; 3 . Screening expiredair carbon monoxide ( ECO ) level ≥ 15 part per million ( ppm ; sample take 30 60 minute smoke single UB cigarette ) ; 4 . Currently smoke combustible , filter , nonmenthol menthol cigarette , 83 mm 100 mm length ; 5 . Selfreports cigarettes tobacco nicotinecontaining product use within 30 day Screening Visit ; 6 . Selfreports Screening Visit smoke least 10 cigarette per day inhale smoke least 6 month prior Screening Visit ; 7 . Response Fagerström Test Nicotine Dependence ( FTND ) Question 1 ( `` How soon wake smoke first cigarette ? '' ) either `` Within 5 minute '' `` 630 minute '' Screening Visit ; 8 . Positive urine cotinine test Screening Enrollment ; 9 . Willing switch current cigarette VUSE Digital Vapor Cigarettes nicotine gum 6 day inclinic confinement ( nonmenthol smoker willing switch VUSE Original Digital Vapor Cigarettes nicotine gum ; menthol smoker willing switch VUSE Menthol Digital Vapor Cigarettes nicotine gum ) ; 10 . Willing abstain tobacco nicotine use least 12 hour twice confinement ; 11 . Willing participate 60 day poststudy donation blood sample study require collection blood sample ; 12 . Females childbearing potential must willing use form contraception acceptable Investigator time sign ICF Study Discharge surgically sterile least 90 day prior Screening Visit ; 13 . Able safely perform require study procedure , determine Investigator . 1 . Clinically significant unstable/uncontrolled acute chronic medical condition screen , determine Investigator , would preclude subject participate safely study ( eg , hypertension , asthma , lung disease , cardiac disease , neurological disease , psychiatric disorder ) base screen assessment safety lab , medical history , physical/oral examination ; 2 . Selfreports safety labs indicate diabetes ; 3 . Selfreports stomach ulcer ; 4 . At risk heart disease , determine Investigator ; 5 . Use medicine treatment depression asthma ; 6 . Systolic blood pressure ≥ 150 mmHg diastolic blood pressure ≥ 95 mmHg , measure seat 5 minute ; 7 . Positive test human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( antiHCV ) ; 8 . Hemoglobin level &lt; 12 g/dL Screening : 9 . History presence hemophilia bleed disorder : 10 . History presence clot disorder concomitant use anticoagulant ( eg , clopidogrel [ Plavix® ] , warfarin [ Coumadin® , Jantoven® ] , aspirin [ &gt; 325 mg/day ] ) ; 11 . Given whole blood donation within 8 week ( ≤ 56 day ) prior Enrollment ; 12 . Plasma donation within ( ≤ ) 7 day prior Enrollment ; 13 . Weight ≤ 110 pound ; 14 . Poor peripheral venous access ; 15 . Postponing decision quit smoking ( define planning quit attempt within 30 day Screening ) participate study ; 16 . Employed tobacco company , clinical site , handle unprocessed tobacco part his/her job ; 17 . Use marijuanabased material within 30 day prior screen ; 18 . Use medication supplement aid smoke cessation , include limited NRT ( eg , nicotine gum , lozenge , patch ) , varenicline ( Chantix® ) , bupropion ( Wellbutrin® , Zyban® ) , lobelia extract within 30 day Screening Visit ; 19 . Use injectable form medication ( ) , exception injectable form birth control require administer study period . 20 . Selfreports drink 14 serving alcoholic beverage per week ( 1 serve = 12 oz beer , 6 oz wine , 1 oz liquor ) ; 21 . Females positive pregnancy test , pregnant , breastfeeding , intend become pregnant course study ; 22 . Females ≥ 35 year age currently use systemic , estrogencontaining contraception , hormone replacement therapy ; 23 . A positive urine drug screen without disclosure correspond prescribe concomitant medication ( ) Screening Visit Enrollment ; 24 . A positive alcohol breathalyzer test Screening Enrollment ; 25 . Regularly exposed solvent fume gasoline ( eg , painter , gas station minimart employee , etc . ) ; 26 . Determined Investigator inappropriate study , include subject unable communicate unwilling cooperate clinical staff ; 27 . Unable unwilling participate inclinic confinement full study duration ( total 9 day ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>biomarkers tobacco exposure</keyword>
	<keyword>exposure</keyword>
	<keyword>tobacco</keyword>
	<keyword>nicotine</keyword>
	<keyword>nicotine gum</keyword>
	<keyword>electronic cigarette</keyword>
	<keyword>e-cig</keyword>
</DOC>